20-33225207-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_178466.5(BPIFA3):c.496G>A(p.Asp166Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00194 in 1,614,086 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 6 hom. )
Consequence
BPIFA3
NM_178466.5 missense
NM_178466.5 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: -3.73
Genes affected
BPIFA3 (HGNC:16204): (BPI fold containing family A member 3) Predicted to enable lipid binding activity. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010327339).
BP6
Variant 20-33225207-G-A is Benign according to our data. Variant chr20-33225207-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3041043.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BPIFA3 | NM_178466.5 | c.496G>A | p.Asp166Asn | missense_variant | 4/7 | ENST00000375454.8 | NP_848561.2 | |
BPIFA3 | NM_001042439.2 | c.388G>A | p.Asp130Asn | missense_variant | 3/6 | NP_001035904.1 | ||
BPIFA3 | XR_244132.4 | n.723G>A | non_coding_transcript_exon_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BPIFA3 | ENST00000375454.8 | c.496G>A | p.Asp166Asn | missense_variant | 4/7 | 5 | NM_178466.5 | ENSP00000364603.3 | ||
BPIFA3 | ENST00000375452.3 | c.388G>A | p.Asp130Asn | missense_variant | 3/6 | 1 | ENSP00000364601.3 | |||
BPIFA3 | ENST00000490499.5 | n.875G>A | non_coding_transcript_exon_variant | 5/7 | 1 | |||||
BPIFA3 | ENST00000471233.1 | n.706G>A | non_coding_transcript_exon_variant | 4/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00110 AC: 167AN: 152130Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
167
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00127 AC: 318AN: 251356Hom.: 0 AF XY: 0.00133 AC XY: 180AN XY: 135836
GnomAD3 exomes
AF:
AC:
318
AN:
251356
Hom.:
AF XY:
AC XY:
180
AN XY:
135836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00203 AC: 2970AN: 1461838Hom.: 6 Cov.: 33 AF XY: 0.00202 AC XY: 1468AN XY: 727216
GnomAD4 exome
AF:
AC:
2970
AN:
1461838
Hom.:
Cov.:
33
AF XY:
AC XY:
1468
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00110 AC: 167AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.00121 AC XY: 90AN XY: 74432
GnomAD4 genome
AF:
AC:
167
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
90
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
11
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
11
ExAC
AF:
AC:
139
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
BPIFA3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at